tirzepatide bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial A Study to Investigate Weight

Both SSTR2 and SSTR5 mediate the antiproliferative effects of SS by tyrosine phosphatase activation and ERK1/2 phosphorylation inhibition, respectively, whereas only SSTR2 and SST3 subtypes mediate apoptotic effects (912)

Using it off-label for weight loss, although not officially approved, is a practice some doctors may endorse

This plan prioritises tolerability and long-term sustainability over aggressive short-term results

pp.74756

It also is disappointing that the study does not go into any details about 8.4% of dogs being treated with pimobendan and which suffered cardiac-related deaths while only in Stage B2